John Ware to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications John Ware has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.055
-
Menter A, Kosinski M, Bresnahan BW, Papp KA, Ware JE. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis. J Drugs Dermatol. 2004 Jan-Feb; 3(1):27-38.
Score: 0.055